C 
0.06
+1.79%
Close of 9 Nov 2026, in USD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
At a glance
Figures in USD, from our data supplier.
Revenue
—
FY2016FY2025
Net income
−$920,168
FY2016FY2025
Free cash flow
−$282,959
FY2016FY2025
Shareholders' equity
−$459,069
FY2016FY2025
Income statement
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | $143,269 | $192,176 | $346,474 | $685,854 | $2.8m | $12.4m | $12.8m | $36.8m | $30.6m |
| Gross profit | — | $105,250 | −$265,640 | −$602,548 | $47,210 | $503,766 | $2.4m | $2.9m | $8.8m | $7.4m |
| Research and development | $2,190 | $6,233 | $101,409 | $203,751 | $308,823 | $249,879 | $348,745 | $518,969 | $376,981 | $326,820 |
| Operating income | −$297,729 | −$456,498 | −$1.6m | −$2.9m | −$2.4m | −$2.5m | −$932,901 | −$1.3m | $3.2m | $3.3m |
| Net income | −$920,168 | −$962,384 | −$1.7m | −$2.7m | −$2.0m | −$2.4m | −$891,669 | −$1.0m | $2.1m | $2.8m |
| Diluted earnings per share | -0.02 | -0.02 | -0.03 | -0.05 | -0.04 | -0.05 | -0.02 | -0.02 | 0.04 | 0.07 |
Balance sheet
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $59,105 | $838,117 | $1.4m | $1.9m | $4.1m | $3.8m | $5.8m | $6.5m | $10.4m | $9.6m |
| Total liabilities | $518,174 | $377,018 | $3.7m | $2.4m | $2.0m | $1.3m | $857,765 | $593,984 | $3.6m | $4.4m |
| Debt | — | — | — | $1.2m | $1.0m | — | — | — | — | $1.3m |
| Shareholders' equity | −$459,069 | $461,099 | −$2.2m | −$545,381 | $2.1m | $2.6m | $5.0m | $5.9m | $6.8m | $5.1m |
| Shares outstanding | 49m | 49m | 49m | 49m | 49m | 46m | 47m | 47m | 47m | 43m |
Cash flow
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | −$282,959 | −$289,548 | −$614,527 | −$1.9m | −$2.4m | −$1.9m | −$585,580 | $208,029 | $3.5m | $4.2m |
| Capital spending | — | — | −$42,970 | — | −$31,928 | −$13,500 | −$34,123 | −$53,866 | −$47,587 | −$53,510 |
| Free cash flow | −$282,959 | −$289,548 | −$657,497 | −$1.9m | −$2.4m | −$1.9m | −$619,703 | $154,163 | $3.4m | $4.2m |
Latest quarters
By quarter end
| Jun 2026 | Mar 2026 | Dec 2025 | Sept 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sept 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | $1 | — |
| Gross profit | — | — | — | — | — | — | $1 | — |
| Operating income | −$71,304 | −$82,210 | −$847,112 | −$64,462 | −$70,429 | −$106,795 | −$64,635 | −$65,523 |
| Net income | −$84,924 | −$92,269 | −$659,719 | −$72,837 | −$76,533 | −$111,079 | −$480,577 | −$95,537 |
| Diluted earnings per share | -0.00 | -0.00 | -0.01 | -0.00 | -0.00 | -0.00 | -0.01 | -0.00 |
| Total assets | $204,527 | $271,997 | $59,105 | $909,354 | $848,842 | $843,152 | $838,117 | $1.4m |
| Shareholders' equity | −$636,262 | −$551,338 | −$459,069 | $200,650 | $273,487 | $350,020 | $461,099 | −$2.7m |
Growth per year
Compound annual rate
| 3 years | 5 years | 10 years | |
|---|---|---|---|
| Operating income | -53.3% | -34.5% | — |
| Net income | -29.8% | -17.3% | — |
Valuation history
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Price to earnings | -1.1 | -0.1 | -0.0 | -0.0 | -0.1 | -0.0 | -0.0 | -0.0 | 0.0 | 0.0 |
| Price to sales | — | 0.5 | 0.1 | 0.1 | 0.2 | 0.0 | — | — | — | — |
Share price return
Finished calendar years
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Return | 1074% | 1065% | -85% | -81% | 1926% | -39% | -6% | -70% | 34% | 3% |
Dividends and splits
Per share, in the currency the company pays
Paid for 0 years.
- 15-to-1 reverse split · 25 Jul 2016
- 4-to-1 reverse split · 8 Dec 1998
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.